Jillian Hung
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.
Journal: Nature genetics
Published: January 06, 2022
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Journal: Mayo Clinic proceedings
Published: July 19, 2017
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 08, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Journal: Nature genetics
Published: June 04, 2016
Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Journal: Gynecologic oncology
Published: May 02, 2016
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.
Journal: Nature
Published: October 28, 2015
Whole-genome characterization of chemoresistant ovarian cancer.
Journal: Nature
Published: December 15, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026